Cargando…
Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations
Owing to considerable differences observed in anatomy and physiology between paediatric subsets, it has been well established that children respond to drugs differently compared to adults. Furthermore, from a formulation perspective, there is a distinct challenge to develop a dosage form that is cap...
Autores principales: | Khan, Dilawar, Kirby, Daniel, Bryson, Simon, Shah, Maryam, Mohammed, Afzal Rahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227311/ https://www.ncbi.nlm.nih.gov/pubmed/34204941 http://dx.doi.org/10.3390/pharmaceutics13060831 |
Ejemplares similares
-
Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use
por: Khan, Dilawar, et al.
Publicado: (2023) -
Current opinions and recommendations of paediatric healthcare professionals – The importance of tablets: Emerging orally disintegrating versus traditional tablets
por: Alyami, Hamad, et al.
Publicado: (2018) -
Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets
por: Koner, Jasdip S., et al.
Publicado: (2019) -
Formulation and development of paediatric orally disintegrating carbamazepine tablets
por: Canadell-Heredia, R, et al.
Publicado: (2022) -
Appropriate usage of food thickening agents to prevent non-disintegration of magnesium oxide tablets
por: Matsuo, Taisuke, et al.
Publicado: (2020)